Guarantor and Non-Guarantor Financial Statements (Details) - USD ($) | 3 Months Ended | 12 Months Ended | | | | |
Dec. 31, 2017 | Sep. 30, 2017 | Jun. 30, 2017 | Mar. 31, 2017 | Dec. 31, 2016 | Sep. 30, 2016 | Jun. 30, 2016 | Mar. 31, 2016 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | Jun. 01, 2016 | May 15, 2016 | Dec. 31, 2014 | May 23, 2012 |
Condensed Financial Statements [Line Items] | | | | | | | | | | | | | | | | |
Ownership interest by parent | | 100.00% | | | | | | | | 100.00% | | | | | | |
Current assets: | | | | | | | | | | | | | | | | |
Cash and cash equivalents | | $ 51,100,000 | | | | $ 55,200,000 | | | | $ 51,100,000 | $ 55,200,000 | $ 72,500,000 | | | | |
Short-term investments | | 183,700,000 | | | | 231,000,000 | | | | 183,700,000 | 231,000,000 | | | | | |
Receivables: | | | | | | | | | | | | | | | | |
Trade, less allowance for doubtful receivables | | 165,000,000 | | | | 137,700,000 | | | | 165,000,000 | 137,700,000 | | | | | |
Intercompany receivables | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Other | | 15,500,000 | | | | 11,900,000 | | | | 15,500,000 | 11,900,000 | | | | | |
Inventories | | 207,900,000 | | | | 201,600,000 | | | | 207,900,000 | 201,600,000 | | | | | |
Prepaid expenses and other current assets | | 33,400,000 | | | | 18,500,000 | | | | 33,400,000 | 18,500,000 | | | | | |
Total current assets | | 656,600,000 | | | | 655,900,000 | | | | 656,600,000 | 655,900,000 | | | | | |
Investments in and advances to unconsolidated affiliates | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Property, plant and equipment, net | | 571,400,000 | | | | 530,900,000 | | | | 571,400,000 | 530,900,000 | | | | | |
Long-term intercompany receivables | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Deferred tax assets — net | | 72,000,000 | | | | 159,700,000 | | | | 72,000,000 | 159,700,000 | | | | | |
Intangible assets, net | | 25,000,000 | | | | 26,400,000 | | | | 25,000,000 | 26,400,000 | | | | | |
Goodwill | | 18,800,000 | | | | 37,200,000 | | | | 18,800,000 | 37,200,000 | | | | | |
Other assets | | 41,400,000 | | | | 33,400,000 | | | | 41,400,000 | 33,400,000 | | | | | |
Total | | 1,385,200,000 | | | | 1,443,500,000 | | | | 1,385,200,000 | 1,443,500,000 | 1,246,900,000 | | | | |
Current liabilities: | | | | | | | | | | | | | | | | |
Accounts payable | | 90,000,000 | | | | 75,800,000 | | | | 90,000,000 | 75,800,000 | | | | | |
Intercompany payable | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Accrued salaries, wages and related expenses | | 42,600,000 | | | | 49,100,000 | | | | 42,600,000 | 49,100,000 | | | | | |
Other accrued liabilities | | 40,500,000 | | | | 40,100,000 | | | | 40,500,000 | 40,100,000 | | | | | |
Total current liabilities | | 173,100,000 | | | | 165,000,000 | | | | 173,100,000 | 165,000,000 | | | | | |
Net liabilities of Salaried VEBA | | 31,900,000 | | | | 28,600,000 | | | | 31,900,000 | 28,600,000 | | | | | |
Deferred tax liabilities | | 4,300,000 | | | | 3,300,000 | | | | 4,300,000 | 3,300,000 | | | | | |
Long-term intercompany payable | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Long-term liabilities | | 60,000,000 | | | | 73,200,000 | | | | 60,000,000 | 73,200,000 | | | | | |
Long-term debt | | 369,600,000 | | | | 368,700,000 | | | | 369,600,000 | 368,700,000 | | | | | |
Total liabilities | | 638,900,000 | | | | 638,800,000 | | | | 638,900,000 | 638,800,000 | | | | | |
Total stockholders’ equity | | 746,300,000 | | | | 804,700,000 | | | | 746,300,000 | 804,700,000 | | | | $ 1,015,900,000 | |
Total | | 1,385,200,000 | | | | 1,443,500,000 | | | | 1,385,200,000 | 1,443,500,000 | | | | | |
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME | | | | | | | | | | | | | | | | |
Net sales | | 353,100,000 | $ 332,800,000 | $ 356,300,000 | $ 355,300,000 | 331,900,000 | $ 320,600,000 | $ 334,900,000 | $ 343,200,000 | 1,397,500,000 | 1,330,600,000 | 1,391,900,000 | | | | |
Cost of products sold: | | | | | | | | | | | | | | | | |
Cost of products sold, excluding depreciation and amortization and other items | | 282,600,000 | 267,200,000 | 277,700,000 | 277,800,000 | 252,400,000 | 254,700,000 | 250,400,000 | 262,000,000 | 1,105,300,000 | 1,019,500,000 | 1,115,400,000 | | | | |
Lower of cost or market inventory write-down | | | | | | 0 | 0 | 0 | 4,900,000 | 0 | 4,900,000 | 2,600,000 | | | | |
Unrealized (gain) loss on derivative instruments | | (5,400,000) | (10,800,000) | 11,900,000 | (15,100,000) | (1,800,000) | (2,000,000) | (10,900,000) | (4,000,000) | (19,400,000) | (18,700,000) | 3,400,000 | | | | |
Depreciation and amortization | | | | | | | | | | 39,700,000 | 36,000,000 | 32,400,000 | | | | |
Selling, general, administrative, research and development | | | | | | | | | | 97,500,000 | 105,000,000 | 88,100,000 | | | | |
Net periodic postretirement benefit cost relating to Salaried VEBA | | | | | | | | | | 4,500,000 | 3,400,000 | 2,400,000 | | | | |
(Gain) loss on removal of Union VEBA net assets – Note 4 | | | | | | | | | | 0 | (100,000) | 493,400,000 | | | | |
Total selling, administrative, research and development and general | | | | | | | | | | 102,000,000 | 108,300,000 | 583,900,000 | | | | |
Goodwill impairment | | | | | | | | | | 18,400,000 | 0 | 0 | | | | |
Other operating charges, net | | | | | | | | | | 800,000 | 2,800,000 | 100,000 | | | | |
Total costs and expenses | | | | | | | | | | 1,246,800,000 | 1,152,800,000 | 1,737,800,000 | | | | |
Operating (loss) income | | 40,000,000 | 39,800,000 | 11,400,000 | 59,500,000 | 45,300,000 | 29,800,000 | 57,900,000 | 44,800,000 | 150,700,000 | 177,800,000 | (345,900,000) | | | | |
Interest expense | | | | | | | | | | (22,200,000) | (20,300,000) | (24,100,000) | | | | |
Other (expense) income: | | | | | | | | | | | | | | | | |
Other income, net | | | | | | | | | | 4,500,000 | (10,300,000) | (1,800,000) | | | | |
(Loss) income before income taxes | | | | | | | | | | 133,000,000 | 147,200,000 | (371,800,000) | | | | |
Income tax provision | | | | | | | | | | (87,600,000) | (55,500,000) | 135,200,000 | | | | |
Earnings in equity of subsidiaries | | | | | | | | | | 0 | 0 | 0 | | | | |
Net income (loss) | | (15,200,000) | $ 19,900,000 | $ 4,700,000 | 36,000,000 | 24,500,000 | $ 14,900,000 | $ 26,000,000 | 26,300,000 | 45,400,000 | 91,700,000 | (236,600,000) | | | | |
Comprehensive (loss) income | | | | | | | | | | 45,400,000 | 86,700,000 | (172,200,000) | | | | |
Cash flows from operating activities: | | | | | | | | | | | | | | | | |
Net cash (used in) provided by operating activities | | | | | | | | | | 141,500,000 | 165,600,000 | 159,700,000 | | | | |
Cash flows from investing activities: | | | | | | | | | | | | | | | | |
Capital expenditures | | | | | | | | | | (75,500,000) | (76,100,000) | (63,100,000) | | | | |
Purchase of available for sale securities | | | | | | | | | | (247,500,000) | (255,300,000) | (500,000) | | | | |
Proceeds from disposition of available for sale securities | | | | | | | | | | 296,900,000 | 55,000,000 | 84,000,000 | | | | |
Proceeds from disposal of property, plant and equipment | | | | | | | | | | 600,000 | 0 | 0 | | | | |
Intercompany loans receivable | | | | | | | | | | 0 | 0 | | | | | |
Net cash (used in) provided by investing activities | [1] | | | | | | | | | (25,500,000) | (276,400,000) | 20,400,000 | | | | |
Repayment of principal and redemption premium of 8.25% Senior Notes | | | | | | | | | | 0 | (206,000,000) | (30,000,000) | | | | |
Issuance of 5.875% Senior Notes | | | | | | | | | | 0 | 375,000,000 | 0 | | | | |
Repayment of Convertible Notes | | | | | | | | | | 0 | 0 | (175,000,000) | | | | |
Proceeds from cash-settled call options related to settlement of Convertible Notes | | | | | | | | | | 0 | 0 | 94,900,000 | | | | |
Payment for conversion premium related to settlement of Convertible Notes | | | | | | | | | | 0 | 0 | (94,900,000) | | | | |
Cash paid for debt issuance costs | | | | | | | | | | 0 | (6,800,000) | (600,000) | | | | |
Proceeds from stock option exercises | | | | | | | | | | 0 | 1,200,000 | 0 | | | | |
Repayment of capital lease | | | | | | | | | | 400,000 | 0 | 0 | | | | |
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest | | | | | | | | | | 0 | 0 | 1,300,000 | | | | |
Cancellation of shares to cover employees' tax withholdings upon vesting of non-vested shares | | | | | | | | | | (4,500,000) | (2,900,000) | (2,800,000) | | | | |
Repurchase of common stock | | | | | | | | | | (79,500,000) | (33,300,000) | (49,200,000) | | | | |
Cash dividends and dividend equivalents paid | | | | | | | | | | (35,000,000) | (32,400,000) | (28,100,000) | | | | |
Cash dividends paid to Parent | | | | | | | | | | | 0 | | | | | |
Intercompany loans payable | | | | | | | | | | 0 | 0 | 0 | | | | |
Net cash (used in) provided by financing activities | [1] | | | | | | | | | (119,400,000) | 94,800,000 | (284,400,000) | | | | |
Net decrease in cash, cash equivalents and restricted cash during the period | | | | | | | | | | (3,400,000) | (16,000,000) | (104,300,000) | | | | |
Cash, cash equivalents and restricted cash at beginning of period | | | | | 67,700,000 | | | | 83,700,000 | 67,700,000 | 83,700,000 | 188,000,000 | | | | |
Cash, cash equivalents and restricted cash at end of period | | 64,300,000 | | | | 67,700,000 | | | | 64,300,000 | 67,700,000 | 83,700,000 | | | | |
Consolidating Adjustments | | | | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | | | | |
Cash and cash equivalents | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Short-term investments | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Receivables: | | | | | | | | | | | | | | | | |
Trade, less allowance for doubtful receivables | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Intercompany receivables | | (23,600,000) | | | | (86,500,000) | | | | (23,600,000) | (86,500,000) | | | | | |
Other | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Inventories | | 0 | | | | (3,900,000) | | | | 0 | (3,900,000) | | | | | |
Prepaid expenses and other current assets | | 0 | | | | (500,000) | | | | 0 | (500,000) | | | | | |
Total current assets | | (23,600,000) | | | | (90,900,000) | | | | (23,600,000) | (90,900,000) | | | | | |
Investments in and advances to unconsolidated affiliates | | (1,145,900,000) | | | | (1,052,500,000) | | | | (1,145,900,000) | (1,052,500,000) | | | | | |
Property, plant and equipment, net | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Long-term intercompany receivables | | (12,400,000) | | | | (85,100,000) | | | | (12,400,000) | (85,100,000) | | | | | |
Deferred tax assets — net | | 4,700,000 | | | | 4,800,000 | | | | 4,700,000 | 4,800,000 | | | | | |
Intangible assets, net | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Goodwill | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Other assets | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Total | | (1,177,200,000) | | | | (1,223,700,000) | | | | (1,177,200,000) | (1,223,700,000) | | | | | |
Current liabilities: | | | | | | | | | | | | | | | | |
Accounts payable | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Intercompany payable | | (23,600,000) | | | | (86,500,000) | | | | (23,600,000) | (86,500,000) | | | | | |
Accrued salaries, wages and related expenses | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Other accrued liabilities | | (9,500,000) | | | | (14,700,000) | | | | (9,500,000) | (14,700,000) | | | | | |
Total current liabilities | | (33,100,000) | | | | (101,200,000) | | | | (33,100,000) | (101,200,000) | | | | | |
Net liabilities of Salaried VEBA | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Deferred tax liabilities | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Long-term intercompany payable | | (12,400,000) | | | | (85,100,000) | | | | (12,400,000) | (85,100,000) | | | | | |
Long-term liabilities | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Long-term debt | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Total liabilities | | (45,500,000) | | | | (186,300,000) | | | | (45,500,000) | (186,300,000) | | | | | |
Total stockholders’ equity | | (1,131,700,000) | | | | (1,037,400,000) | | | | (1,131,700,000) | (1,037,400,000) | | | | | |
Total | | (1,177,200,000) | | | | (1,223,700,000) | | | | (1,177,200,000) | (1,223,700,000) | | | | | |
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME | | | | | | | | | | | | | | | | |
Net sales | | | | | | | | | | (83,500,000) | (74,400,000) | (93,000,000) | | | | |
Cost of products sold: | | | | | | | | | | | | | | | | |
Cost of products sold, excluding depreciation and amortization and other items | | | | | | | | | | (81,300,000) | (71,100,000) | (88,600,000) | | | | |
Lower of cost or market inventory write-down | | | | | | | | | | | 0 | 0 | | | | |
Unrealized (gain) loss on derivative instruments | | | | | | | | | | 0 | 0 | 0 | | | | |
Depreciation and amortization | | | | | | | | | | 0 | 0 | 0 | | | | |
Selling, general, administrative, research and development | | | | | | | | | | (2,200,000) | (2,600,000) | (2,000,000) | | | | |
Net periodic postretirement benefit cost relating to Salaried VEBA | | | | | | | | | | 0 | 0 | 0 | | | | |
(Gain) loss on removal of Union VEBA net assets – Note 4 | | | | | | | | | | | 0 | 0 | | | | |
Total selling, administrative, research and development and general | | | | | | | | | | (2,200,000) | (2,600,000) | (2,000,000) | | | | |
Goodwill impairment | | | | | | | | | | 0 | | | | | | |
Other operating charges, net | | | | | | | | | | 0 | 0 | 0 | | | | |
Total costs and expenses | | | | | | | | | | (83,500,000) | (73,700,000) | (90,600,000) | | | | |
Operating (loss) income | | | | | | | | | | 0 | (700,000) | (2,400,000) | | | | |
Interest expense | | | | | | | | | | 200,000 | 100,000 | 300,000 | | | | |
Other (expense) income: | | | | | | | | | | | | | | | | |
Other income, net | | | | | | | | | | (200,000) | (100,000) | (300,000) | | | | |
(Loss) income before income taxes | | | | | | | | | | 0 | (700,000) | (2,400,000) | | | | |
Income tax provision | | | | | | | | | | 9,500,000 | 14,100,000 | 11,400,000 | | | | |
Earnings in equity of subsidiaries | | | | | | | | | | (74,900,000) | (130,300,000) | 205,400,000 | | | | |
Net income (loss) | | | | | | | | | | (65,400,000) | (116,900,000) | 214,400,000 | | | | |
Comprehensive (loss) income | | | | | | | | | | (65,400,000) | (111,900,000) | 150,000,000 | | | | |
Cash flows from operating activities: | | | | | | | | | | | | | | | | |
Net cash (used in) provided by operating activities | | | | | | | | | | 0 | (200,000,000) | 0 | | | | |
Cash flows from investing activities: | | | | | | | | | | | | | | | | |
Capital expenditures | | | | | | | | | | 0 | 0 | 0 | | | | |
Purchase of available for sale securities | | | | | | | | | | 0 | 0 | 0 | | | | |
Proceeds from disposition of available for sale securities | | | | | | | | | | 0 | 0 | 0 | | | | |
Proceeds from disposal of property, plant and equipment | | | | | | | | | | 0 | | | | | | |
Intercompany loans receivable | | | | | | | | | | (135,600,000) | 56,900,000 | | | | | |
Net cash (used in) provided by investing activities | | | | | | | | | | (135,600,000) | 56,900,000 | 0 | | | | |
Repayment of principal and redemption premium of 8.25% Senior Notes | | | | | | | | | | | 0 | 0 | | | | |
Issuance of 5.875% Senior Notes | | | | | | | | | | | 0 | | | | | |
Repayment of Convertible Notes | | | | | | | | | | | | 0 | | | | |
Proceeds from cash-settled call options related to settlement of Convertible Notes | | | | | | | | | | | | 0 | | | | |
Payment for conversion premium related to settlement of Convertible Notes | | | | | | | | | | | | 0 | | | | |
Cash paid for debt issuance costs | | | | | | | | | | | 0 | 0 | | | | |
Proceeds from stock option exercises | | | | | | | | | | | 0 | | | | | |
Repayment of capital lease | | | | | | | | | | 0 | | | | | | |
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest | | | | | | | | | | | | 0 | | | | |
Cancellation of shares to cover employees' tax withholdings upon vesting of non-vested shares | | | | | | | | | | 0 | 0 | 0 | | | | |
Repurchase of common stock | | | | | | | | | | 0 | 0 | 0 | | | | |
Cash dividends and dividend equivalents paid | | | | | | | | | | 0 | 0 | 0 | | | | |
Cash dividends paid to Parent | | | | | | | | | | | 200,000,000 | | | | | |
Intercompany loans payable | | | | | | | | | | 135,600,000 | (56,900,000) | 0 | | | | |
Net cash (used in) provided by financing activities | | | | | | | | | | 135,600,000 | 143,100,000 | 0 | | | | |
Net decrease in cash, cash equivalents and restricted cash during the period | | | | | | | | | | 0 | 0 | 0 | | | | |
Cash, cash equivalents and restricted cash at beginning of period | | | | | 0 | | | | 0 | 0 | 0 | 0 | | | | |
Cash, cash equivalents and restricted cash at end of period | | 0 | | | | 0 | | | | 0 | 0 | 0 | | | | |
Parent Company [Member] | | | | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | | | | |
Cash and cash equivalents | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Short-term investments | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Receivables: | | | | | | | | | | | | | | | | |
Trade, less allowance for doubtful receivables | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Intercompany receivables | | 22,800,000 | | | | 85,800,000 | | | | 22,800,000 | 85,800,000 | | | | | |
Other | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Inventories | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Prepaid expenses and other current assets | | 100,000 | | | | 100,000 | | | | 100,000 | 100,000 | | | | | |
Total current assets | | 22,900,000 | | | | 85,900,000 | | | | 22,900,000 | 85,900,000 | | | | | |
Investments in and advances to unconsolidated affiliates | | 1,097,700,000 | | | | 1,012,400,000 | | | | 1,097,700,000 | 1,012,400,000 | | | | | |
Property, plant and equipment, net | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Long-term intercompany receivables | | 0 | | | | 80,200,000 | | | | 0 | 80,200,000 | | | | | |
Deferred tax assets — net | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Intangible assets, net | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Goodwill | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Other assets | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Total | | 1,120,600,000 | | | | 1,178,500,000 | | | | 1,120,600,000 | 1,178,500,000 | | | | | |
Current liabilities: | | | | | | | | | | | | | | | | |
Accounts payable | | 1,900,000 | | | | 2,200,000 | | | | 1,900,000 | 2,200,000 | | | | | |
Intercompany payable | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Accrued salaries, wages and related expenses | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Other accrued liabilities | | 2,800,000 | | | | 2,900,000 | | | | 2,800,000 | 2,900,000 | | | | | |
Total current liabilities | | 4,700,000 | | | | 5,100,000 | | | | 4,700,000 | 5,100,000 | | | | | |
Net liabilities of Salaried VEBA | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Deferred tax liabilities | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Long-term intercompany payable | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Long-term liabilities | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Long-term debt | | 369,600,000 | | | | 368,700,000 | | | | 369,600,000 | 368,700,000 | | | | | |
Total liabilities | | 374,300,000 | | | | 373,800,000 | | | | 374,300,000 | 373,800,000 | | | | | |
Total stockholders’ equity | | 746,300,000 | | | | 804,700,000 | | | | 746,300,000 | 804,700,000 | | | | | |
Total | | 1,120,600,000 | | | | 1,178,500,000 | | | | 1,120,600,000 | 1,178,500,000 | | | | | |
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME | | | | | | | | | | | | | | | | |
Net sales | | | | | | | | | | 0 | 0 | 0 | | | | |
Cost of products sold: | | | | | | | | | | | | | | | | |
Cost of products sold, excluding depreciation and amortization and other items | | | | | | | | | | 0 | 0 | 0 | | | | |
Lower of cost or market inventory write-down | | | | | | | | | | | 0 | 0 | | | | |
Unrealized (gain) loss on derivative instruments | | | | | | | | | | 0 | 0 | 0 | | | | |
Depreciation and amortization | | | | | | | | | | 0 | 0 | 0 | | | | |
Selling, general, administrative, research and development | | | | | | | | | | 4,500,000 | 4,200,000 | 4,300,000 | | | | |
Net periodic postretirement benefit cost relating to Salaried VEBA | | | | | | | | | | 0 | 0 | 0 | | | | |
(Gain) loss on removal of Union VEBA net assets – Note 4 | | | | | | | | | | | 0 | 0 | | | | |
Total selling, administrative, research and development and general | | | | | | | | | | 4,500,000 | 4,200,000 | 4,300,000 | | | | |
Goodwill impairment | | | | | | | | | | 0 | | | | | | |
Other operating charges, net | | | | | | | | | | 0 | 0 | 0 | | | | |
Total costs and expenses | | | | | | | | | | 4,500,000 | 4,200,000 | 4,300,000 | | | | |
Operating (loss) income | | | | | | | | | | (4,500,000) | (4,200,000) | (4,300,000) | | | | |
Interest expense | | | | | | | | | | (20,700,000) | (21,600,000) | (23,500,000) | | | | |
Other (expense) income: | | | | | | | | | | | | | | | | |
Other income, net | | | | | | | | | | 0 | (11,100,000) | (2,500,000) | | | | |
(Loss) income before income taxes | | | | | | | | | | (25,200,000) | (36,900,000) | (30,300,000) | | | | |
Income tax provision | | | | | | | | | | 0 | 0 | 0 | | | | |
Earnings in equity of subsidiaries | | | | | | | | | | 70,600,000 | 128,600,000 | (206,300,000) | | | | |
Net income (loss) | | | | | | | | | | 45,400,000 | 91,700,000 | (236,600,000) | | | | |
Comprehensive (loss) income | | | | | | | | | | 45,400,000 | 86,700,000 | (172,200,000) | | | | |
Cash flows from operating activities: | | | | | | | | | | | | | | | | |
Net cash (used in) provided by operating activities | | | | | | | | | | (24,200,000) | 177,700,000 | 285,700,000 | | | | |
Cash flows from investing activities: | | | | | | | | | | | | | | | | |
Capital expenditures | | | | | | | | | | 0 | 0 | 0 | | | | |
Purchase of available for sale securities | | | | | | | | | | 0 | 0 | 0 | | | | |
Proceeds from disposition of available for sale securities | | | | | | | | | | 0 | 0 | 0 | | | | |
Proceeds from disposal of property, plant and equipment | | | | | | | | | | 0 | | | | | | |
Intercompany loans receivable | | | | | | | | | | 143,200,000 | (166,000,000) | | | | | |
Net cash (used in) provided by investing activities | | | | | | | | | | 143,200,000 | (166,000,000) | 0 | | | | |
Repayment of principal and redemption premium of 8.25% Senior Notes | | | | | | | | | | | (206,000,000) | (30,000,000) | | | | |
Issuance of 5.875% Senior Notes | | | | | | | | | | | 375,000,000 | | | | | |
Repayment of Convertible Notes | | | | | | | | | | | | (175,000,000) | | | | |
Proceeds from cash-settled call options related to settlement of Convertible Notes | | | | | | | | | | | | 94,900,000 | | | | |
Payment for conversion premium related to settlement of Convertible Notes | | | | | | | | | | | | (94,900,000) | | | | |
Cash paid for debt issuance costs | | | | | | | | | | | (6,800,000) | (600,000) | | | | |
Proceeds from stock option exercises | | | | | | | | | | | 1,200,000 | | | | | |
Repayment of capital lease | | | | | | | | | | 0 | | | | | | |
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest | | | | | | | | | | | | 0 | | | | |
Cancellation of shares to cover employees' tax withholdings upon vesting of non-vested shares | | | | | | | | | | (4,500,000) | (2,900,000) | (2,800,000) | | | | |
Repurchase of common stock | | | | | | | | | | (79,500,000) | (33,300,000) | (49,200,000) | | | | |
Cash dividends and dividend equivalents paid | | | | | | | | | | (35,000,000) | (32,400,000) | (28,100,000) | | | | |
Cash dividends paid to Parent | | | | | | | | | | | 0 | | | | | |
Intercompany loans payable | | | | | | | | | | 0 | (106,500,000) | 0 | | | | |
Net cash (used in) provided by financing activities | | | | | | | | | | (119,000,000) | (11,700,000) | (285,700,000) | | | | |
Net decrease in cash, cash equivalents and restricted cash during the period | | | | | | | | | | 0 | 0 | 0 | | | | |
Cash, cash equivalents and restricted cash at beginning of period | | | | | 0 | | | | 0 | 0 | 0 | 0 | | | | |
Cash, cash equivalents and restricted cash at end of period | | 0 | | | | 0 | | | | 0 | 0 | 0 | | | | |
Guarantor Subsidiaries | | | | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | | | | |
Cash and cash equivalents | | 48,400,000 | | | | 52,900,000 | | | | 48,400,000 | 52,900,000 | | | | | |
Short-term investments | | 183,700,000 | | | | 231,000,000 | | | | 183,700,000 | 231,000,000 | | | | | |
Receivables: | | | | | | | | | | | | | | | | |
Trade, less allowance for doubtful receivables | | 160,100,000 | | | | 133,100,000 | | | | 160,100,000 | 133,100,000 | | | | | |
Intercompany receivables | | 100,000 | | | | 100,000 | | | | 100,000 | 100,000 | | | | | |
Other | | 14,700,000 | | | | 11,400,000 | | | | 14,700,000 | 11,400,000 | | | | | |
Inventories | | 198,700,000 | | | | 197,500,000 | | | | 198,700,000 | 197,500,000 | | | | | |
Prepaid expenses and other current assets | | 32,900,000 | | | | 18,000,000 | | | | 32,900,000 | 18,000,000 | | | | | |
Total current assets | | 638,600,000 | | | | 644,000,000 | | | | 638,600,000 | 644,000,000 | | | | | |
Investments in and advances to unconsolidated affiliates | | 48,200,000 | | | | 40,100,000 | | | | 48,200,000 | 40,100,000 | | | | | |
Property, plant and equipment, net | | 541,200,000 | | | | 499,500,000 | | | | 541,200,000 | 499,500,000 | | | | | |
Long-term intercompany receivables | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Deferred tax assets — net | | 67,300,000 | | | | 154,900,000 | | | | 67,300,000 | 154,900,000 | | | | | |
Intangible assets, net | | 25,000,000 | | | | 26,400,000 | | | | 25,000,000 | 26,400,000 | | | | | |
Goodwill | | 18,800,000 | | | | 37,200,000 | | | | 18,800,000 | 37,200,000 | | | | | |
Other assets | | 41,400,000 | | | | 33,400,000 | | | | 41,400,000 | 33,400,000 | | | | | |
Total | | 1,380,500,000 | | | | 1,435,500,000 | | | | 1,380,500,000 | 1,435,500,000 | | | | | |
Current liabilities: | | | | | | | | | | | | | | | | |
Accounts payable | | 81,400,000 | | | | 68,900,000 | | | | 81,400,000 | 68,900,000 | | | | | |
Intercompany payable | | 23,500,000 | | | | 86,400,000 | | | | 23,500,000 | 86,400,000 | | | | | |
Accrued salaries, wages and related expenses | | 41,000,000 | | | | 47,200,000 | | | | 41,000,000 | 47,200,000 | | | | | |
Other accrued liabilities | | 46,200,000 | | | | 52,600,000 | | | | 46,200,000 | 52,600,000 | | | | | |
Total current liabilities | | 192,100,000 | | | | 255,100,000 | | | | 192,100,000 | 255,100,000 | | | | | |
Net liabilities of Salaried VEBA | | 31,900,000 | | | | 28,600,000 | | | | 31,900,000 | 28,600,000 | | | | | |
Deferred tax liabilities | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Long-term intercompany payable | | 12,400,000 | | | | 85,100,000 | | | | 12,400,000 | 85,100,000 | | | | | |
Long-term liabilities | | 58,000,000 | | | | 70,500,000 | | | | 58,000,000 | 70,500,000 | | | | | |
Long-term debt | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Total liabilities | | 294,400,000 | | | | 439,300,000 | | | | 294,400,000 | 439,300,000 | | | | | |
Total stockholders’ equity | | 1,086,100,000 | | | | 996,200,000 | | | | 1,086,100,000 | 996,200,000 | | | | | |
Total | | 1,380,500,000 | | | | 1,435,500,000 | | | | 1,380,500,000 | 1,435,500,000 | | | | | |
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME | | | | | | | | | | | | | | | | |
Net sales | | | | | | | | | | 1,365,300,000 | 1,301,600,000 | 1,361,600,000 | | | | |
Cost of products sold: | | | | | | | | | | | | | | | | |
Cost of products sold, excluding depreciation and amortization and other items | | | | | | | | | | 1,085,500,000 | 1,000,600,000 | 1,095,600,000 | | | | |
Lower of cost or market inventory write-down | | | | | | | | | | | 4,900,000 | 2,600,000 | | | | |
Unrealized (gain) loss on derivative instruments | | | | | | | | | | (19,400,000) | (18,700,000) | 3,400,000 | | | | |
Depreciation and amortization | | | | | | | | | | 37,500,000 | 34,000,000 | 31,300,000 | | | | |
Selling, general, administrative, research and development | | | | | | | | | | 88,300,000 | 95,000,000 | 76,500,000 | | | | |
Net periodic postretirement benefit cost relating to Salaried VEBA | | | | | | | | | | 4,500,000 | 3,400,000 | 2,400,000 | | | | |
(Gain) loss on removal of Union VEBA net assets – Note 4 | | | | | | | | | | | (100,000) | 493,400,000 | | | | |
Total selling, administrative, research and development and general | | | | | | | | | | 92,800,000 | 98,300,000 | 572,300,000 | | | | |
Goodwill impairment | | | | | | | | | | 18,400,000 | | | | | | |
Other operating charges, net | | | | | | | | | | 800,000 | 2,800,000 | 100,000 | | | | |
Total costs and expenses | | | | | | | | | | 1,215,600,000 | 1,121,900,000 | 1,705,300,000 | | | | |
Operating (loss) income | | | | | | | | | | 149,700,000 | 179,700,000 | (343,700,000) | | | | |
Interest expense | | | | | | | | | | (1,700,000) | 1,200,000 | (900,000) | | | | |
Other (expense) income: | | | | | | | | | | | | | | | | |
Other income, net | | | | | | | | | | 4,000,000 | 900,000 | 3,500,000 | | | | |
(Loss) income before income taxes | | | | | | | | | | 152,000,000 | 181,800,000 | (341,100,000) | | | | |
Income tax provision | | | | | | | | | | (95,200,000) | (69,000,000) | 122,500,000 | | | | |
Earnings in equity of subsidiaries | | | | | | | | | | 4,300,000 | 1,700,000 | 900,000 | | | | |
Net income (loss) | | | | | | | | | | 61,100,000 | 114,500,000 | (217,700,000) | | | | |
Comprehensive (loss) income | | | | | | | | | | 61,100,000 | 109,800,000 | (153,500,000) | | | | |
Cash flows from operating activities: | | | | | | | | | | | | | | | | |
Net cash (used in) provided by operating activities | | | | | | | | | | 156,900,000 | 178,700,000 | (126,300,000) | | | | |
Cash flows from investing activities: | | | | | | | | | | | | | | | | |
Capital expenditures | | | | | | | | | | (74,700,000) | (74,000,000) | (47,900,000) | | | | |
Purchase of available for sale securities | | | | | | | | | | (247,500,000) | (255,300,000) | (500,000) | | | | |
Proceeds from disposition of available for sale securities | | | | | | | | | | 296,900,000 | 55,000,000 | 84,000,000 | | | | |
Proceeds from disposal of property, plant and equipment | | | | | | | | | | 600,000 | | | | | | |
Intercompany loans receivable | | | | | | | | | | 0 | 110,400,000 | | | | | |
Net cash (used in) provided by investing activities | | | | | | | | | | (24,700,000) | (163,900,000) | 35,600,000 | | | | |
Repayment of principal and redemption premium of 8.25% Senior Notes | | | | | | | | | | | 0 | 0 | | | | |
Issuance of 5.875% Senior Notes | | | | | | | | | | | 0 | | | | | |
Repayment of Convertible Notes | | | | | | | | | | | | 0 | | | | |
Proceeds from cash-settled call options related to settlement of Convertible Notes | | | | | | | | | | | | 0 | | | | |
Payment for conversion premium related to settlement of Convertible Notes | | | | | | | | | | | | 0 | | | | |
Cash paid for debt issuance costs | | | | | | | | | | | 0 | 0 | | | | |
Proceeds from stock option exercises | | | | | | | | | | | 0 | | | | | |
Repayment of capital lease | | | | | | | | | | 400,000 | | | | | | |
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest | | | | | | | | | | | | 1,300,000 | | | | |
Cancellation of shares to cover employees' tax withholdings upon vesting of non-vested shares | | | | | | | | | | 0 | 0 | 0 | | | | |
Repurchase of common stock | | | | | | | | | | 0 | 0 | 0 | | | | |
Cash dividends and dividend equivalents paid | | | | | | | | | | 0 | 0 | 0 | | | | |
Cash dividends paid to Parent | | | | | | | | | | | (200,000,000) | | | | | |
Intercompany loans payable | | | | | | | | | | (135,600,000) | 167,300,000 | (12,800,000) | | | | |
Net cash (used in) provided by financing activities | | | | | | | | | | (136,000,000) | (32,700,000) | (11,500,000) | | | | |
Net decrease in cash, cash equivalents and restricted cash during the period | | | | | | | | | | (3,800,000) | (17,900,000) | (102,200,000) | | | | |
Cash, cash equivalents and restricted cash at beginning of period | | | | | 65,100,000 | | | | 83,000,000 | 65,100,000 | 83,000,000 | 185,200,000 | | | | |
Cash, cash equivalents and restricted cash at end of period | | 61,300,000 | | | | 65,100,000 | | | | 61,300,000 | 65,100,000 | 83,000,000 | | | | |
Non-Guarantor Subsidiaries | | | | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | | | | |
Cash and cash equivalents | | 2,700,000 | | | | 2,300,000 | | | | 2,700,000 | 2,300,000 | | | | | |
Short-term investments | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Receivables: | | | | | | | | | | | | | | | | |
Trade, less allowance for doubtful receivables | | 4,900,000 | | | | 4,600,000 | | | | 4,900,000 | 4,600,000 | | | | | |
Intercompany receivables | | 700,000 | | | | 600,000 | | | | 700,000 | 600,000 | | | | | |
Other | | 800,000 | | | | 500,000 | | | | 800,000 | 500,000 | | | | | |
Inventories | | 9,200,000 | | | | 8,000,000 | | | | 9,200,000 | 8,000,000 | | | | | |
Prepaid expenses and other current assets | | 400,000 | | | | 900,000 | | | | 400,000 | 900,000 | | | | | |
Total current assets | | 18,700,000 | | | | 16,900,000 | | | | 18,700,000 | 16,900,000 | | | | | |
Investments in and advances to unconsolidated affiliates | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Property, plant and equipment, net | | 30,200,000 | | | | 31,400,000 | | | | 30,200,000 | 31,400,000 | | | | | |
Long-term intercompany receivables | | 12,400,000 | | | | 4,900,000 | | | | 12,400,000 | 4,900,000 | | | | | |
Deferred tax assets — net | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Intangible assets, net | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Goodwill | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Other assets | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Total | | 61,300,000 | | | | 53,200,000 | | | | 61,300,000 | 53,200,000 | | | | | |
Current liabilities: | | | | | | | | | | | | | | | | |
Accounts payable | | 6,700,000 | | | | 4,700,000 | | | | 6,700,000 | 4,700,000 | | | | | |
Intercompany payable | | 100,000 | | | | 100,000 | | | | 100,000 | 100,000 | | | | | |
Accrued salaries, wages and related expenses | | 1,600,000 | | | | 1,900,000 | | | | 1,600,000 | 1,900,000 | | | | | |
Other accrued liabilities | | 1,000,000 | | | | (700,000) | | | | 1,000,000 | (700,000) | | | | | |
Total current liabilities | | 9,400,000 | | | | 6,000,000 | | | | 9,400,000 | 6,000,000 | | | | | |
Net liabilities of Salaried VEBA | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Deferred tax liabilities | | 4,300,000 | | | | 3,300,000 | | | | 4,300,000 | 3,300,000 | | | | | |
Long-term intercompany payable | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Long-term liabilities | | 2,000,000 | | | | 2,700,000 | | | | 2,000,000 | 2,700,000 | | | | | |
Long-term debt | | 0 | | | | 0 | | | | 0 | 0 | | | | | |
Total liabilities | | 15,700,000 | | | | 12,000,000 | | | | 15,700,000 | 12,000,000 | | | | | |
Total stockholders’ equity | | 45,600,000 | | | | 41,200,000 | | | | 45,600,000 | 41,200,000 | | | | | |
Total | | 61,300,000 | | | | 53,200,000 | | | | 61,300,000 | 53,200,000 | | | | | |
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME | | | | | | | | | | | | | | | | |
Net sales | | | | | | | | | | 115,700,000 | 103,400,000 | 123,300,000 | | | | |
Cost of products sold: | | | | | | | | | | | | | | | | |
Cost of products sold, excluding depreciation and amortization and other items | | | | | | | | | | 101,100,000 | 90,000,000 | 108,400,000 | | | | |
Lower of cost or market inventory write-down | | | | | | | | | | | 0 | 0 | | | | |
Unrealized (gain) loss on derivative instruments | | | | | | | | | | 0 | 0 | 0 | | | | |
Depreciation and amortization | | | | | | | | | | 2,200,000 | 2,000,000 | 1,100,000 | | | | |
Selling, general, administrative, research and development | | | | | | | | | | 6,900,000 | 8,400,000 | 9,300,000 | | | | |
Net periodic postretirement benefit cost relating to Salaried VEBA | | | | | | | | | | 0 | 0 | 0 | | | | |
(Gain) loss on removal of Union VEBA net assets – Note 4 | | | | | | | | | | | 0 | 0 | | | | |
Total selling, administrative, research and development and general | | | | | | | | | | 6,900,000 | 8,400,000 | 9,300,000 | | | | |
Goodwill impairment | | | | | | | | | | 0 | | | | | | |
Other operating charges, net | | | | | | | | | | 0 | 0 | 0 | | | | |
Total costs and expenses | | | | | | | | | | 110,200,000 | 100,400,000 | 118,800,000 | | | | |
Operating (loss) income | | | | | | | | | | 5,500,000 | 3,000,000 | 4,500,000 | | | | |
Interest expense | | | | | | | | | | 0 | 0 | 0 | | | | |
Other (expense) income: | | | | | | | | | | | | | | | | |
Other income, net | | | | | | | | | | 700,000 | 0 | (2,500,000) | | | | |
(Loss) income before income taxes | | | | | | | | | | 6,200,000 | 3,000,000 | 2,000,000 | | | | |
Income tax provision | | | | | | | | | | (1,900,000) | (600,000) | 1,300,000 | | | | |
Earnings in equity of subsidiaries | | | | | | | | | | 0 | 0 | 0 | | | | |
Net income (loss) | | | | | | | | | | 4,300,000 | 2,400,000 | 3,300,000 | | | | |
Comprehensive (loss) income | | | | | | | | | | 4,300,000 | 2,100,000 | 3,500,000 | | | | |
Cash flows from operating activities: | | | | | | | | | | | | | | | | |
Net cash (used in) provided by operating activities | | | | | | | | | | 8,800,000 | 9,200,000 | 300,000 | | | | |
Cash flows from investing activities: | | | | | | | | | | | | | | | | |
Capital expenditures | | | | | | | | | | (800,000) | (2,100,000) | (15,200,000) | | | | |
Purchase of available for sale securities | | | | | | | | | | 0 | 0 | 0 | | | | |
Proceeds from disposition of available for sale securities | | | | | | | | | | 0 | 0 | 0 | | | | |
Proceeds from disposal of property, plant and equipment | | | | | | | | | | 0 | | | | | | |
Intercompany loans receivable | | | | | | | | | | (7,600,000) | (1,300,000) | | | | | |
Net cash (used in) provided by investing activities | | | | | | | | | | (8,400,000) | (3,400,000) | (15,200,000) | | | | |
Repayment of principal and redemption premium of 8.25% Senior Notes | | | | | | | | | | | 0 | 0 | | | | |
Issuance of 5.875% Senior Notes | | | | | | | | | | | 0 | | | | | |
Repayment of Convertible Notes | | | | | | | | | | | | 0 | | | | |
Proceeds from cash-settled call options related to settlement of Convertible Notes | | | | | | | | | | | | 0 | | | | |
Payment for conversion premium related to settlement of Convertible Notes | | | | | | | | | | | | 0 | | | | |
Cash paid for debt issuance costs | | | | | | | | | | | 0 | 0 | | | | |
Proceeds from stock option exercises | | | | | | | | | | | 0 | | | | | |
Repayment of capital lease | | | | | | | | | | 0 | | | | | | |
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest | | | | | | | | | | | | 0 | | | | |
Cancellation of shares to cover employees' tax withholdings upon vesting of non-vested shares | | | | | | | | | | 0 | 0 | 0 | | | | |
Repurchase of common stock | | | | | | | | | | 0 | 0 | 0 | | | | |
Cash dividends and dividend equivalents paid | | | | | | | | | | 0 | 0 | 0 | | | | |
Cash dividends paid to Parent | | | | | | | | | | | 0 | | | | | |
Intercompany loans payable | | | | | | | | | | 0 | (3,900,000) | 12,800,000 | | | | |
Net cash (used in) provided by financing activities | | | | | | | | | | 0 | (3,900,000) | 12,800,000 | | | | |
Net decrease in cash, cash equivalents and restricted cash during the period | | | | | | | | | | 400,000 | 1,900,000 | (2,100,000) | | | | |
Cash, cash equivalents and restricted cash at beginning of period | | | | | $ 2,600,000 | | | | $ 700,000 | 2,600,000 | 700,000 | 2,800,000 | | | | |
Cash, cash equivalents and restricted cash at end of period | | $ 3,000,000 | | | | $ 2,600,000 | | | | $ 3,000,000 | $ 2,600,000 | $ 700,000 | | | | |
Senior Notes | Senior Notes Due 2024 | | | | | | | | | | | | | | | | |
Condensed Financial Statements [Line Items] | | | | | | | | | | | | | | | | |
Principal amount of notes | | | | | | | | | | | | | | $ 375,000,000 | | |
Debt Instrument, Interest Rate, Stated Percentage | | | | | | | | | | | | | | 5.875% | | |
Senior Notes | Senior Notes Due 2020 | | | | | | | | | | | | | | | | |
Condensed Financial Statements [Line Items] | | | | | | | | | | | | | | | | |
Principal amount of notes | | | | | | | | | | | | | | | | $ 225,000,000 |
Debt Instrument, Interest Rate, Stated Percentage | | | | | | | | | | | | | | | | 8.25% |
Current liabilities: | | | | | | | | | | | | | | | | |
Long-term debt | | | | | | | | | | | | | $ 197,800,000 | | | |
| |
[1] | See Note 14 for supplemental disclosure on non-cash transactions. | |